Home News Covid-19

Q&M shares surge 41% as it enters joint venture to manufacture Covid-19 test kits, vaccines

Felicia Tan
Felicia Tan4/23/2020 11:23 AM GMT+08  • 3 min read
Q&M shares surge 41% as it enters joint venture to manufacture Covid-19 test kits, vaccines
Q&M Dental Group announced Thursday it is entering into a proposed joint venture to manufacture, sell and distribute diagnostic test kits and vaccines, including for Covid-19.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (Apr 23): Q&M Dental Group announced Thursday it is entering into a proposed joint venture to manufacture, sell and distribute diagnostic test kits and vaccines, including for Covid-19.

Q&M’s wholly-owned subsidiary Acumen Diagnostics (JVC) on April 22 entered into a business transfer agreement with Acumen Research Laboratories (ARL) and its sole shareholder, Dr Ong Siew Hwa.

Under the agreement, JVC will acquire the parts of ARL’s businesses that deal with the manufacture, sale and distribution of Covid-19 diagnostic test kits and vaccines, as well as the analysis of test results and conduct of clinical vaccine trials.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.